跳至主要内容
临床试验/NCT00165438
NCT00165438已完成不适用

A Prospective Study of Pulmonary Function in Patients With Hodgkin's Disease Receiving Bleomycin-Based Chemotherapy With or Without Mediastinal Irradiation

Dana-Farber Cancer Institute2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2001年10月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
60
试验地点
2
主要终点
Pulmonary function

研究概览

简要总结

The purpose of this study is to find out the impact Bleomycin-containing chemotherapy, given with or without chest radiation therapy, on patients' lung function over time.

详细描述

  • The tests and procedures in this study are part of regular cancer care but this study offers more structured timing of these standard tests.
  • Due to the potential lung toxicity associated with bleomycin-based chemotherapy, pulmonary function tests are routinely performed. Pulmonary function tests will be performed by a licensed, registered respiratory therapist and performed prior to the beginning of treatment, between the chemotherapy and radiation therapy (only for patients receiving both chemotherapy and radiation therapy), and at approximately 1 month, 6 months, 1 year and 2 years after the completion of all treatments.
  • A CAT scan will be performed prior to the beginning of treatment, and approximately 1 month, 6 months, 1 year and 2 years after the completion of all treatments.
  • A self-administered questionnaire will be performed on the days the patient is undergoing pulmonary function tests.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Patients with newly diagnosed classical Hodgkin's disease, with mediastinal involvement
  • •Bleomycin-based chemotherapy alone or in combination with mediastinal irradiation

排除标准

  • •Prior chest irradiation
  • •Mediastinal irradiation received at an outside institution
  • •Refractory or progressive disease on treatment

结局指标

主要结局

Pulmonary function

时间窗: 2 years

Changes in pulmonary function over time

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Andrea K. Ng, MD

Principal Investigator

Dana-Farber Cancer Institute

研究点 (2)

Loading locations...

相似试验